LAVIPHARM S.A. NA EO 1 Cash Flow Quality Index
LAVIPHARM S.A. NA EO 1 cash flow quality index. LAVIPHARM S.A. NA EO 1 (BXA0) has a Cash Flow Quality Index of 0.52x as of December 2024. Operating cash flow of €4.64 Million is below net income of €8.98 Million, suggesting accrual-heavy earnings not yet converted to cash. See LAVIPHARM S.A. NA EO 1 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of LAVIPHARM S.A. NA EO 1 (2021–2024)
Cash flow quality index of LAVIPHARM S.A. NA EO 1 from 2021 to 2024. Historical Cash Flow Quality Index for LAVIPHARM S.A. NA EO 1 across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore LAVIPHARM S.A. NA EO 1 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
LAVIPHARM S.A. NA EO 1 Cash Flow Quality Index by Year (2021–2024)
LAVIPHARM S.A. NA EO 1 cash flow quality index by year from 2021 to 2024. Year-by-year earnings quality comparison for LAVIPHARM S.A. NA EO 1. For the full cash flow conversion analysis, see LAVIPHARM S.A. NA EO 1 operating cash flow efficiency.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | €4.64 Million | €8.98 Million | ▲ +240.3% |
| 2023 | 0.15x | €284.00K | €1.87 Million | ▼ -96.2% |
| 2022 | 4.01x | €3.35 Million | €834.00K | ▲ +68.2% |
| 2021 | 2.38x | €4.11 Million | €1.72 Million | — |